Probi AB (publ) – LSE:0GZB.L

Probi AB (publ) stock price today

SEK 399
+190.00
+90.91%
Financial Health
0
1
2
3
4
5
6
7
8
9

Probi AB (publ) stock price monthly change

-45.65%
month

Probi AB (publ) stock price quarterly change

-45.65%
quarter

Probi AB (publ) stock price yearly change

-50.71%
year

Probi AB (publ) key metrics

Market Cap
 2.31B
Enterprise value
 N/A
P/E
 N/A
EV/Sales
 N/A
EV/EBITDA
 N/A
Price/Sales
 N/A
Price/Book
 N/A
PEG ratio
 N/A
EPS
 -0.06
Revenue
 607.54M
EBITDA
 58.66M
Income
 -602K
Revenue Q/Q
 -11.72%
Revenue Y/Y
 -4.38%
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 9.66%

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Probi AB (publ) stock price history

Probi AB (publ) stock forecast

Probi AB (publ) financial statements

Profit Margin

Probi AB (publ) (LSE:0GZB.L): Profit margin
Jun 2023 143.71M -6.26M -4.36%
Sep 2023 156.03M 6.39M 4.1%
Dec 2023 156.12M -2.59M -1.66%
Mar 2024 151.67M 1.85M 1.22%
0GZB.L income statement history
0%
Yield TTM
Probi AB (publ) (LSE:0GZB.L): Payout ratio
Payout ratio 0%
Probi AB (publ) (LSE:0GZB.L): Dividend Yield
2019
2020 0.26%
2021 0.29%
2022 0.64%
2023 0.64%
0GZB.L dividends history

Debt to Assets

Probi AB (publ) (LSE:0GZB.L): Debt to assets
Jun 2023 1595775000 148.70M 9.32%
Sep 2023 1589652000 138.47M 8.71%
Dec 2023 1490443000 121.36M 8.14%
Mar 2024 1537135000 111.00M 7.22%
0GZB.L balance sheet history

Cash Flow

Probi AB (publ) (LSE:0GZB.L): Cash Flow
Jun 2023 8.95M -9.17M -18.78M
Sep 2023 16.94M -13.13M -4.07M
Dec 2023 46.85M -17.53M 2.70M
Mar 2024 18.88M -7.45M -3.96M
0GZB.L cash flow history

Probi AB (publ) alternative data

Probi AB (publ)
Employees

Probi AB (publ) (LSE:0GZB.L): Employee count
Aug 2023 154
Sep 2023 164
Oct 2023 164
Nov 2023 168
Dec 2023 168
Jan 2024 168
Feb 2024 160
Mar 2024 160
Apr 2024 160
May 2024 167
Jun 2024 167
Jul 2024 167

Probi AB (publ) other data

Probi AB (publ)
Executives

Insider Compensation
Mr. Tom Rönnlund (1972) Chief Executive Officer
 $3,970,000
Mr. Henrik Lundkvist Chief Financial Officer
Mr. Andy McShea Vice President of Global Operations
Dr. Niklas Larsson Ph.D. Lead Scientific Affairs
Mr. Shane Judge Global Vice President of Sales & Marketing
Ms. Basudha Bhattarai-Johansson Vice President of Human Relations
Anna-Karin Robertson Head of Discovery
Ms. Magdolna Dimén Group Controller

Frequently Asked Questions (FAQ)

  • What's the price of Probi AB (publ) stock today?

    One share of Probi AB (publ) stock can currently be purchased for approximately $399.

  • When is Probi AB (publ)'s next earnings date?

    Probi AB (publ) is estimated to report earnings on Monday, 20 Oct 2025.

  • Does Probi AB (publ) pay dividends?

    No, Probi AB (publ) does not pay dividends.

  • How much money does Probi AB (publ) make?

    Probi AB (publ) has a market capitalization of 2.31B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 1.52% to 627.69M US dollars.

  • What is Probi AB (publ)'s stock symbol?

    Probi AB (publ) is traded on the LSE under the ticker symbol "0GZB.L".

  • What is Probi AB (publ)'s primary industry?

    Company operates in the Healthcare sector and Medical - Pharmaceuticals industry.

  • How do i buy shares of Probi AB (publ)?

    Shares of Probi AB (publ) can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Probi AB (publ)'s key executives?

    Probi AB (publ)'s management team includes the following people:

    • Mr. Tom Rönnlund Chief Executive Officer(age: 53, pay: $3,970,000)
    • Mr. Henrik Lundkvist Chief Financial Officer
    • Mr. Andy McShea Vice President of Global Operations
    • Dr. Niklas Larsson Ph.D. Lead Scientific Affairs
    • Mr. Shane Judge Global Vice President of Sales & Marketing
    • Ms. Basudha Bhattarai-Johansson Vice President of Human Relations
    • Anna-Karin Robertson Head of Discovery
    • Ms. Magdolna Dimén Group Controller

  • How many employees does Probi AB (publ) have?

    As Jul 2024, Probi AB (publ) employs 167 workers, which is 4% more then previous quarter.

  • When Probi AB (publ) went public?

    Probi AB (publ) is publicly traded company for more then 27 years since IPO on 1 Jan 1998.

  • What is Probi AB (publ)'s official website?

    The official website for Probi AB (publ) is probi.com.

  • How can i contact Probi AB (publ)?

    Probi AB (publ) can be reached via phone at +46 46 286 89 20.

Probi AB (publ) company profile:

Probi AB (publ)

probi.com
Exchange:

LSE

Full time employees:

157

Industry:

Medical - Pharmaceuticals

Sector:

Healthcare

Probi AB (publ) researches, develops, manufactures, markets, and sells probiotics for health, pharmaceutical, and food companies. The company conducts research primarily in the fields of gastrointestinal health, digestive health, immune health, bone health, and iron absorption, as well as children's, women's, and senior health. It provides dietary supplement, and food and beverage products in the form of capsules, tablets and spheres, chewable tablets, powder, fruit drinks, shots, carbonated beverages, and recovery drinks. The company sells its products approximately in 40 countries worldwide. It has a collaboration with Örebro University for research into exploration needle free vaccines; and a collaboration with La Trobe University to conduct a clinical trial to investigate the effect of Probi Osteo in an Australian women. The company was incorporated in 1991 and is headquartered in Lund, Sweden. Probi AB (publ) is a subsidiary of Symrise AG.

+46 46 286 89 20
Ideongatan 1A
Lund, 223 70

:
ISIN: SE0001280355
CUSIP: W6740R131